1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
South & Central America RNAi Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Molecule Type, Application, Route of Administration, and End User ; and Country

South & Central America RNAi Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Molecule Type, Application, Route of Administration, and End User ; and Country

  • December 2020
  • 114 pages
  • ID: 6004244
  • Format: PDF
  • The Insight Partners
Up to $1000 off Until Mar 10th 2021

Summary

Table of Contents

Search Inside

The South & Central America closed systems drug transfer devices market is expected to reach US$ 118.49 million by 2027 from US$ 28.37 million in 2019; it is estimated to grow at a CAGR of 19.6% from 2020 to 2027.
The closed systems drug transfer devices market in South & Central America is primarily driven by rise in adoption of chemotherapy and improvement of regulatory guidelines regarding hazardous drugs.However, the lack of regulatory guidelines regarding the safety of health workers in emerging countries restricts the growth of the market.

Additionally, continuous technological advancements in handling of hazardous drugs and rising number of chemotherapeutic drug approvals are expected to fuel the growth of the South & Central America closed systems drug transfer devices market during the forecast period.
Closed system drug transfer devices provide protection against hazardous drugs or vapors during drug preparation and administration.These devices comprise components to filter dangerous vapors.

Closed system drug transfer devices play a major role in providing protection to healthcare professionals who are in close proximity to antineoplastic drugs and other harmful medications. Government authorities are emphasizing on the implementation of occupational health and safety standards, which, in turn, offers lucrative growth opportunities for the South & Central America closed systems drug transfer devices market.
Several hazardous drugs, such as monoclonal antibodies, antineoplastics, and antibiotics, are used during patient treatment protocols.Pharmacists, nurses, physicians, and other healthcare workers are at great risk of exposure to hazardous drugs.

The cancer treatment comprises utilization of antineoplastic drugs that can cause several health implications if ingested.The antineoplastic can have a severe impact during pregnancies, and the exposure can lead to chromosomal abnormalities.

The surface contamination of chemotherapy treatment can impact not only healthcare professionals but also patients and their families.Increasing number of cancer cases are anticipated to drive the adoption of chemotherapies.

For instance, according to Cancer Atlas, in 2018, approximately 1.3 million new cancer cases and 666,000 cancer deaths were estimated in Latin America. The five common cancers in 2018 were female breast cancer (200,000 new cases, 15% of all cancer cases), prostate cancer (190,000, 14%), colorectal (128,000, 9%), lung (90,000, 7%) and stomach cancer (67,000, 5%). Lung cancer is the leading cause of death (81,000, 12%), followed by colorectal cancer (65,000 10%), prostate (54,000, 8%), female breast (53,000, 8%) and stomach (52,000, 8%). Thus, the consequent surge in adopting chemotherapies would eventually drive the demand for closed systems drug transfer devices in the coming years.
The COVID-19 pandemic hit the South & Central American countries causing huge effect on the economy and society.Additionally, The COVID-19 pandemic has disrupted the spectrum of cancer care, including delaying diagnoses and treatment and halting clinical trials.

Along with this, many medical companies have shifted their focus of manufacturing from closed systems drug transfer devices to respiratory devices. Such problems are likely to have a negative impact on the research and development activities, which would directly restrain the growth of the closed system drug transfer device market in the region.
In 2019, the push-to-turn systems segment accounted for the largest share of the market.The growth of this segment is attributed to increasing preference for push-to-turn mechanism, as it offers superior protection and availability of the product incorporating push-to-turn mechanism.

Furthermore, the luer-lock systems segment is expected to register the highest CAGR in the closed systems drug transfer devices market during the forecast period.
A few major secondary sources referred while preparing the South & Central America closed systems drug transfer devices market report are the World Health Organization, Globocan Cancer Statistics 2018, Cancer Atlas organization, and Brazilian National Cancer Institute.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

$3000

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Asia Pacific Addictions Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment Type ; Drug Type ; Treatment Center ; Distribution Channel and Country

  • $ 3000
  • December 2020
  • 97 pages

The Asia Pacific addictions therapeutics market is expected to reach US$ 1,781.09 million by 2027 from US$ 1,060.33 million in 2019. The market is estimated to grow with a CAGR of 6.8% from 2020 to 2027. The ...

  • APAC
  • Therapy
  • Industry analysis
  • Smoking Prevalence
  • Psychoactive Drug Consumption

ref:plp2020

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on